Literature DB >> 18319500

Ciprofloxacin-induced Q-T interval prolongation.

John P Knorr1, Mersedeh Moshfeghi, Mary C Sokoloski.   

Abstract

PURPOSE: A case of Q-T interval prolongation in a pediatric patient with no known risk factors for the development of a long Q-T syndrome is reported.
SUMMARY: A 16-year-old boy arrived at a children's hospital reporting mucous diarrhea that had lasted two weeks, light-headedness with two blackouts on the day before his arrival to the hospital, and a 4.3-kg weight loss over the previous three weeks. He had a 3.5-year history of Crohn's disease and had been hospitalized for two months with a diagnosis of colitis with cryptitis. He was admitted for the treatment of an acute flare of Crohn's disease and a perirectal abscess. The patient was started on i.v. ciprofloxacin 400 mg twice daily and metronidazole 500 mg every six hours. The selected agents provided adequate empirical coverage of the suspected organisms and would not be contraindicated with the patient's allergy to penicillin. Within 48 hours of administration of ciprofloxacin, the patient became bradycardic. The cardiology service was consulted, and an electrocardiogram showed a mildly prolonged Q-T interval (corrected Q-T interval, 486 msec) and low heart rate (42 beats/min). Antimicrobial therapy was changed to ampicillin and then to linezolid. The patient's Q-T interval normalized within seven days of ciprofloxacin discontinuation. The patient had no further cardiac anomalies. Two weeks later, he was discharged on linezolid and aztreonam for the treatment of his abscess and was responding to treatment.
CONCLUSION: A pediatric patient with Crohn's disease and colitis with cryptitis developed a prolonged Q-T interval within 48 hours of treatment with ciprofloxacin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18319500     DOI: 10.2146/ajhp070081

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  7 in total

1.  Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone.

Authors:  Tony Antoniou; Simon Hollands; Erin M Macdonald; Tara Gomes; Muhammad M Mamdani; David N Juurlink
Journal:  CMAJ       Date:  2015-02-02       Impact factor: 8.262

2.  [Severe bacterial infection: increased mortality in elderly women with low body weight taking drugs prolonging the QTc interval].

Authors:  S Suefke; H Djonlagić; T Kibbel
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-04-29       Impact factor: 0.840

3.  A Rare Case of Metronidazole Overdose Causing Ventricular Fibrillation.

Authors:  Mohamed Abdelgadir M Elgassim; Amin Saied Sanosi Saied; Moayad A Mustafa; Amro Abdelrahman; Ibtesam AlJaufi; Waleed Salem
Journal:  Cureus       Date:  2022-05-04

Review 4.  Role of antibiotics for treatment of inflammatory bowel disease.

Authors:  Orna Nitzan; Mazen Elias; Avi Peretz; Walid Saliba
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

5.  Evaluation of QT and P wave dispersion and mean platelet volume among inflammatory bowel disease patients.

Authors:  Yuksel Dogan; Aliye Soylu; Gulay A Eren; Sule Poturoglu; Can Dolapcioglu; Kenan Sonmez; Habibe Duman; Isa Sevindir
Journal:  Int J Med Sci       Date:  2011-09-16       Impact factor: 3.738

6.  Toxicological assessment of trace β-diketone antibiotic mixtures on zebrafish (Danio rerio) by proteomic analysis.

Authors:  Xiaohan Yin; Huili Wang; Yuna Zhang; Randy A Dahlgren; Hongqin Zhang; Mengru Shi; Ming Gao; Xuedong Wang
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

7.  Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study.

Authors:  Michael Fralick; Erin M Macdonald; Tara Gomes; Tony Antoniou; Simon Hollands; Muhammad M Mamdani; David N Juurlink
Journal:  BMJ       Date:  2014-10-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.